SLC29A1 and kidney disorder: Given SLC29A1’s role in regulating adenosine levels inside and outside the cell, adenosine reuptake inhibitors have been used to block SLC29A1 function for vasodilation, antithrombosis, hypertension, and renal disorders (Yoshida et al., 1994; Young et al., 2008; FitzGerald 1987; Boswell-Casteel and Hays, 2017; Wright and Lee, 2019).